{
    "title": "113_hr5790",
    "content": "The Act titled \"Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014\" introduces prize competitions for improving health outcomes and reducing federal expenditures under the Public Health Service Act. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 aims to improve health outcomes and reduce Federal expenditures on health programs through prize competitions. Within 6 months of enactment, the Director of NIH will identify 3 to 5 diseases or health conditions with significant Federal spending on prevention and treatment activities but limited research investment compared to other similar diseases. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 directs the Director of NIH to design prize competitions within 12 months to achieve the goal of improving health outcomes and reducing Federal expenditures on health programs. The competitions will focus on diseases or conditions with significant Federal spending on prevention and treatment activities but limited research investment compared to other similar diseases. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 mandates prize competitions to improve health outcomes and reduce Federal health program expenditures. Competitions will focus on diseases with high Federal spending but limited research investment. Prizes will be awarded to competitors with promising innovations and best solutions, ensuring realistic design and unbiased participation. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 mandates prize competitions to address unmet needs in health innovation. The Director of NIH will consult with experts and relevant federal agencies to design these competitions. The Director of NIH is required to conduct a simulation of prize competitions under the Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014. The simulation will assess the design effectiveness, with a report due to Congress within 4 months of awarding contracts. Adjustments to the competition design must be made within 21 months based on simulation results. The Director of NIH will adjust prize competition designs based on simulation results and submit a report to Congress. Private entities will implement competitions requiring innovation effectiveness demonstration over a maximum of 5 years. Qualified competitors may receive guidance and access to testing facilities from the Secretary and the Commissioner of Food and Drugs. The Secretary and the Commissioner of Food and Drugs can collaborate with qualified competitors in up to 5 prize competitions, with a limit of 2 competitions per disease. The Director of NIH will track and report on the medical efficacy and cost impact of innovations funded through these competitions to Congress annually for 5 years. The Federal Government must report to Congress annually on information collected from prize competitions. The government cannot acquire intellectual property without participant consent, but can negotiate licenses. $50,000,000 is authorized for implementing prize competitions, with a minimum percentage allocated for prizes. The Federal Government must report annually on prize competitions, with a minimum percentage allocated for prizes. Gross income excludes certain prizes for improving health outcomes."
}